Pioglitazone Improves Left Ventricular Diastolic Function

Share this content:
Pioglitazone Improves Left Ventricular Diastolic Function
Pioglitazone Improves Left Ventricular Diastolic Function

FRIDAY, Sept. 29, 2017 (HealthDay News) -- Pioglitazone improves whole-body and myocardial insulin sensitivity, left ventricular (LV) diastolic function, and systolic function in patients with type 2 diabetes, according to a small study published online Sept. 22 in Diabetes Care.

Geoffrey D. Clarke, Ph.D., from the University of Texas Health Science Center in San Antonio, and colleagues used a euglycemic insulin clamp in 12 subjects with type 2 diabetes and 12 with normal glucose tolerance. They measured myocardial glucose uptake and myocardial perfusion before and after 24 weeks of treatment with pioglitazone.

The researchers found that pioglitazone reduced HbA1c by 0.9 percent; decreased systolic and diastolic blood pressure by 7 mmHg each (P < 0.05); and increased whole-body insulin-stimulated glucose uptake by 71 percent (P < 0.01) in subjects with type 2 diabetes. Pioglitazone enhanced myocardial glucose uptake by 75 percent (P < 0.01) and myocardial perfusion by 16 percent (P < 0.05). There were also increases in measures of diastolic function, early diastolic relation/atrial contraction flow ratio, and peak LV filling rate (P < 0.01). There were nonsignificant increases in end-systolic volume, end-diastolic volume, peak LV ejection rate, and cardiac output and significant increases in ejection fraction and stroke volume (P < 0.05).

"Improved myocardial insulin sensitivity and diastolic function are strongly correlated," conclude the authors.

Several authors disclosed financial ties to pharmaceutical companies, including Takeda Pharmaceuticals, which partially funded the study.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »